De’ Longhi Group: a Quarter of Robust Revenue Growth of 8.4% and Solid Margin Expansion Drives an Upward Guidance Revision July 30, 2026 Substantial expansion in Professional and acceleration in Household drive growth and margins, enabling further investments in marketing and product innovation as part of the Group's continuous strategic evolution
DNA Payments Launches DNA Engage, a New Way for Businesses to Connect With Customers July 30, 2026 DNA Payments has launched DNA Engage, an innovative platform powered by Taployo that helps merchants turn every payment into an opportunity to build customer relationships, drive loyalty, and gain actionable business insights. DNA Engage enables businesses of any size to turn their receipts into branded post-purchase experiences through personalised receipts, targeted promotions, Google Reviews, surveys, [...]
Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential July 30, 2026 VRB-103, a potential once-weekly, selective oral amylin analog, is being evaluated in a Phase 1 study as both a monotherapy and in combination with VRB-101 (oral ecnoglutide), a once-weekly oral GLP-1 analog Once-weekly oral dosing of both VRB-103 and VRB-101 enabled by clinically validated, potential best-in-class peptide delivery platform VRB-103 is the first known, once-weekly oral amylin analog currently in clinical development Initial data currently anticipated by the end of 2026
Western Europe’s Fashion E-commerce Market Matures, Representing 20% of Online Consumer Spending as Gen Z Drives momentum July 30, 2026 Second-hand platforms and value-focused retailers are disrupting Western Europe’s fashion market, which accounts for nearly one-fifth of online spending
Iksuda receives US FDA IND clearance for IKS04 July 30, 2026 CA242-directed ADC approved for assessment in Phase 1 trials in patients with GI cancers The ‘IKS04 Regimen’ is an innovative dosing approach for an ADC which is employed to overcome the challenge of solid tumour penetration for high-potency payloads
Carta Rearchitects Private Capital Operations with Plugins for Claude July 29, 2026 Firms managing billions in assets are cutting days of manual fund and portfolio work down to a single prompt — a shift now available to all Carta customers through Anthropic's official plugin directory.
Quality Pays: New Vrbo Research Finds Travelers Will Spend More on Vacation Rentals They Trust July 29, 2026 Vrbo’s new ‘Built to Stay’ Report reveals the quality standards and trust signals that matter most to travelers 86% of travelers would pay more for a vacation rental with a higher-quality listing, rising to 92% among Gen Z 81% would pay more for a property with strong trust signals: verified, recent, and detailed reviews top the list
Arendt Launches AVA, Its Proprietary AI-powered Prospectus Compliance Review Tool July 29, 2026 Arendt & Medernach, the leading independent Luxembourg-based law firm specialising in business law, investment funds, corporate law and tax, announced the launch of AVA (Arendt Visa Agent), a proprietary, purpose-built AI solution designed for UCITS prospectus compliance review. Developed in-house and built on Arendt’s own legal knowledge and methodology, with the technical architecture delivered in [...]
VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment July 29, 2026 Company Engages Stillwater Capital to Explore Strategic M&A Opportunities Amid Growing Demand for Objective Assessments
Oxane Partners Announces Strategic Growth Investment From TA July 29, 2026 Oxane Partners (“Oxane” or “the Company”), a leading technology-driven solutions provider to the private credit industry, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. This investment will support Oxane’s continued technology innovation, expansion of AI capabilities, and further investment in talent and leadership. This press release features [...]